CBUS vs. AMLX
CBUS (Cibus Global LLC) and AMLX (Amylyx Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, CBUS returned -54.05%/yr vs -10.96%/yr for AMLX. At a 0.19 correlation, their price movements are largely independent.
Performance
CBUS vs. AMLX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CBUS achieves a -25.29% return, which is significantly lower than AMLX's 34.77% return.
CBUS
- 1D
- -4.41%
- 1M
- -5.80%
- YTD
- -25.29%
- 6M
- -26.14%
- 1Y
- -13.33%
- 3Y*
- -54.05%
- 5Y*
- —
- 10Y*
- —
AMLX
- 1D
- 3.89%
- 1M
- 19.88%
- YTD
- 34.77%
- 6M
- 30.24%
- 1Y
- 222.38%
- 3Y*
- -10.96%
- 5Y*
- —
- 10Y*
- —
CBUS vs. AMLX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
CBUS Cibus Global LLC | -25.29% | -37.41% | -85.85% | -37.65% |
AMLX Amylyx Pharmaceuticals, Inc. | 34.77% | 219.58% | -74.32% | -40.38% |
Correlation
The correlation between CBUS and AMLX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 2023 | 0.19 |
Fundamentals
CBUS:
$847.63M
AMLX:
$1.80B
CBUS:
-$0.34
AMLX:
-$1.55
CBUS:
23.89
AMLX:
6.59
CBUS:
$4.29M
AMLX:
$0.00
CBUS:
-$164.00K
AMLX:
-$20.10M
CBUS:
-$34.28M
AMLX:
-$150.30M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CBUS vs. AMLX — Risk / Return Rank
CBUS
AMLX
CBUS vs. AMLX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cibus Global LLC (CBUS) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CBUS | AMLX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.46 | ||
| Sortino ratioReturn per unit of downside risk | -3.27 | ||
| Omega ratioGain probability vs. loss probability | 1.07 | 1.44 | -0.37 |
| Calmar ratioReturn relative to maximum drawdown | -0.19 | 7.31 | -7.50 |
| Martin ratioReturn relative to average drawdown | -0.38 | 15.68 | -16.06 |
Loading charts...
Drawdowns
CBUS vs. AMLX - Drawdown Comparison
The maximum CBUS drawdown since its inception was -96.32%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for CBUS and AMLX.
Loading charts...
Drawdown Indicators
| CBUS | AMLX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.32% | -96.04% | -0.28% |
Max Drawdown (1Y)Largest decline over 1 year | -70.37% | -30.61% | -39.76% |
Max Drawdown (3Y)Largest decline over 3 years | -95.14% | -93.09% | -2.05% |
Current DrawdownCurrent decline from peak | -95.87% | -60.22% | -35.65% |
Average DrawdownAverage peak-to-trough decline | -75.47% | -59.40% | -16.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 34.95% | 14.25% | +20.70% |
Volatility
CBUS vs. AMLX - Volatility Comparison
Cibus Global LLC (CBUS) and Amylyx Pharmaceuticals, Inc. (AMLX) have volatilities of 16.95% and 16.44%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CBUS | AMLX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.95% | 16.44% | +0.51% |
Volatility (6M)Calculated over the trailing 6-month period | 90.00% | 43.21% | +46.79% |
Volatility (1Y)Calculated over the trailing 1-year period | 104.74% | 67.39% | +37.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 109.49% | 91.47% | +18.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 109.49% | 91.47% | +18.02% |
Dividends
CBUS vs. AMLX - Dividend Comparison
Neither CBUS nor AMLX has paid dividends to shareholders.
Financials
CBUS vs. AMLX - Financials Comparison
This section allows you to compare key financial metrics between Cibus Global LLC and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
CBUS and AMLX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CBUS has higher volatility (16.95%) compared to AMLX (16.44%). In terms of maximum drawdown, CBUS dropped -96.32% vs AMLX's -96.04%.
AMLX currently has the higher Sharpe Ratio (3.33 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CBUS and AMLX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer